Key Findings
The global intraocular lens market by Europe was valued at $XX million in 2018 and is expected to reach $XX million by 2027 with a CAGR of 4.55% during the forecast period. The economic burden due to eye disorders and vision impairment is likely to increase the market demand in the coming years from the region.

Market Insights
Europe accounted for the second largest share of the global intraocular lenses market in 2018. Presence of advanced healthcare facilities & skilled professionals and high healthcare expenditure are major factors driving the growth of the European intraocular lenses market.

As the life expectancy of people increases, the number of people with cataract will also increase. With the improvement in cataract surgery, the results over the past few years have been surprising which is driving the intraocular lens market.

Competitive Insights
The major key players involved in the intraocular lens market are Carl Zeiss AG, Lenstec, Inc., Bausch Health Companies Inc. (formerly Valent Pharmaceuticals International Inc.), Essilor International S.A., Eyekon Medical Inc., Abbott Medical Optics, Inc. (subsidiary of Abbott Laboratories, Inc.), Alcon, Johnson & Johnson, Inc., Rayner Intraocular Lenses Ltd., Pfizer, Santen Pharmaceutical Co., Ltd., Hoya Corporation, HumanOptics AG, Staar Surgical Company, and others.